InvestorsHub Logo
Followers 27
Posts 675
Boards Moderated 0
Alias Born 07/26/2017

Re: None

Wednesday, 05/02/2018 5:23:41 PM

Wednesday, May 02, 2018 5:23:41 PM

Post# of 698594
IMO the only relevant objective going forward for NWBO now that their shareholders have voiced their support is to make sure they start delivering starting with the publication before they start going back for more financing.
It is time that they start taking their job of delivering seriously and that should start with increasing SP and market cap and avoid toxic financing at all costs.
I look forward to a concerted and timed effort by the company leading into ASCO to get the short nonsense squared away by delivering on blinded paper and spring refresh results as well as starting some additional trials with L and re-starting Direct trials.
With a string of news leading into ASCO I believe the market in general will start taking this companies future seriously and this will of course reflect on the SP and have a massive effect on any future financing required by LP and team.
We as shareholders will of course be reflecting on our own genius in backing this little Bio.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News